ライフサイエンスコーパス: bronchioalveolar

1 es were: squamous cell, 6; adenocarcinoma or bronchioalveolar, 15; large cell, 1; small cell, 3.

2 sequential events, spontaneous emphysema and bronchioalveolar adenocarcinoma were developed as a resu

3 c mice induces chronic inflammation and lung bronchioalveolar adenocarcinoma.

4 -phase effector functions of NK cells in the bronchioalveolar and lung tissue.

5 a, acute lymphoblastic leukemia, meningioma, bronchioalveolar carcinoma, basal cell carcinoma, and ca

6 ression patterns from histologically defined bronchioalveolar carcinoma, squamous cell carcinoma, and

7 y carcinoma, a unique animal model for human bronchioalveolar carcinoma.

8 t case-controlled clinical studies show that bronchioalveolar carcinomas (BAC) are correlated with sm

9 emodeling and transcriptional changes in the bronchioalveolar CD11c+ compartment.

10 e, mimicking the cellular composition of the bronchioalveolar compartment as defined by single-cell R

11 he putative bronchoalveolar stem cell at the bronchioalveolar duct junction as a cancer cell of origi

12 Bronchiolar and bronchioalveolar duct junction hyperplasias were primari

13 Identified at the bronchioalveolar duct junction, BASCs were resistant to

14 lveolar type II cells and hyperplasia in the bronchioalveolar duct region.

15 tential to differentiate into all major lung bronchioalveolar epithelium cell types in homeostasis or

16 oxicities of grade 3 pneumonitis and grade 5 bronchioalveolar hemorrhage were noted.

17 ive, single center study comparing levels of bronchioalveolar lavage (BAL) and serum HA and the HA im

18 Replication-competent virus was detected in bronchioalveolar lavage (BAL) macrophages beyond 6 month

19 ected animals were increased in frequency in bronchioalveolar lavage and decreased in lymph nodes, co

20 c lung compliance and injury scores, reduced bronchioalveolar lavage cell counts and cytokine levels,

21 Injury was assessed by lung mechanics, bronchioalveolar lavage cell counts, protein content, an

22 enase, or hospitalization for pneumonia with bronchioalveolar lavage demonstrating Pneumocystis jirov

23 tein, showed increased concentration in both bronchioalveolar lavage fluid (BALF) and blood of doxycy

24 nhibitory factor (MIF) in serum, sputum, and bronchioalveolar lavage fluid (BALF) from asthmatic pati

25 We found that relative bronchioalveolar lavage fluid adenosine levels are progr

26 In bronchioalveolar lavage fluid and plasma of doxycycline-

27 d human anti-RSV mucosal IgA was detected in bronchioalveolar lavage fluid for up to 6 weeks.

28 inflammation, neutrophil predominance in the bronchioalveolar lavage fluid, and enhanced airway mucus

29 levels, defined as adenosine levels found in bronchioalveolar lavage fluid, were determined in mouse

30 n of interleukin-6 was steadily increased in bronchioalveolar lavage fluid, which activated the oncog

31 l-sn-glycero-3-phosphorylcholine (oxPAPC) in bronchioalveolar lavage fluid.

32 induced in the lungs and cells derived from bronchioalveolar lavage of cotton rats infected with RSV

33 the lung and assessment of leukocytes in the bronchioalveolar lavage revealed that neutrophil numbers

34 tionally similar to those recovered from the bronchioalveolar lavage, based on ex vivo cytokine produ

35 Bronchioalveolar lavage, whole-lung cellular isolation,

36 nse to respiratory virus infections, both in bronchioalveolar lavages from COVID-19 patients and in p

37 established a three-dimensional (3D) murine bronchioalveolar lung organoid (BALO) model that allows

38 (2020) report a murine lung stem cell-based bronchioalveolar organoid system and provide insights in

39 IgG, monocytes, B cells and T cells into the bronchioalveolar space combined with expansion of CD69(+

40 ibitor aurothiomalate inhibits Kras-mediated bronchioalveolar stem cell expansion and lung tumor grow

41 ed the frequency and activity of multipotent bronchioalveolar stem cells (BASCs) and bronchiolar prog

42 s such as label retention and harboring rare bronchioalveolar stem cells (BASCs) in terminal bronchio

43 ulates the temporal appearance and number of bronchioalveolar stem cells (BASCs) in the lung, its abs

44 rts a growing narrative-a rare population of bronchioalveolar stem cells (BASCs) that can contribute

45 pansion and self-organization of FACS-sorted bronchioalveolar stem cells (BASCs) upon co-culture with

46 ndothelial cells and distal lung stem cells, bronchioalveolar stem cells (BASCs), to probe the instru

47 ional pulmonary stem cell population, termed bronchioalveolar stem cells (BASCs).

48 CS-isolated populations, we demonstrate that bronchioalveolar stem cells and club cells are the likel

49 Bronchioalveolar stem cells are expanded in normal and t

50 h a defect in the ability of Prkci-deficient bronchioalveolar stem cells to undergo Kras-mediated exp

51 naling profile of alveolar type II cells and bronchioalveolar stem cells.

52 opment was preceded by aberrant expansion of bronchioalveolar stem/progenitor and alveolar type II (A

53 in the kidney capsule produce differentiated bronchioalveolar tissue, while retaining self-renewal, a

54 Jaagsiekte sheep retrovirus (JSRV) induces bronchioalveolar tumors in sheep and goats.

55 gastric neuroendocrine hyperplasia, and lung bronchioalveolar tumors later in life.